NCT06836557Phase 3Completed

Open Label Safety Study of Tradipitant in Idiopathic and Diabetic Gastroparesis

Study sponsor: Vanda Pharmaceuticals

Primary completion is the date data collection ends for the main study measures, not when results are published.

Primary completion2026-03-30Actual
Enrollment · participants17Actual
Source updated2026-10-19Last update listed in the registry record

Changes to this trial

Last 12 months
Filters
Clear filters

· 5 fields changed

Participant count type changed

Before: Estimated. After: Actual.

Enrollment · participant count changed

Before: 100 participants (planned). After: 17 participants (actual).

Completion date type changed

Before: Estimated. After: Actual.

Primary completion date changed

Before: Dec 2025. After: 30 Mar 2026.

Recruitment status changed

Before: Recruiting. After: Completed.

Check registry source